Abstract: Examples of the present invention include methods of assembling structures, such as nanostructures, at predetermined locations on a substrate. A voltage between spaced-apart electrodes supported by substrate attracts the structures to the substrate, and positional registration can be provided the substrate using topographic features such as wells. Examples of the present invention also include devices, such as electronic and optoelectronic devices, prepared by such methods.
Type:
Application
Filed:
January 9, 2009
Publication date:
October 1, 2009
Applicant:
The Penn State Research Foundation
Inventors:
Theresa S. Mayer, Christine D. Keating, Mingwei Li, Thomas Morrow, Jaekyun Kim
Abstract: The present invention is directed to a method of modulating (e.g., inducing, inhibiting) activation of a double stranded RNA (dsRNA) signaling pathway, such as the dsRNA signaling pathway that accompanies RNA interference (RNAi) of a target RNA sequence, in a cell, comprising introducing into the cell small interfering RNA (siRNA) that degrades the target RNA sequence, and maintaining the cell under conditions in which RNAi of the target RNA sequence occurs and activation of the dsRNA signaling pathway is modulated in the cell.
Type:
Application
Filed:
March 27, 2008
Publication date:
October 1, 2009
Applicant:
The Cleveland Clinic Foundation
Inventors:
Joao Trindade Marques, Bryan R. G. Williams
Abstract: A novel and stable attenuated poliovirus, which replicates in neuroblastoma cells, is produced by engineering an indigenous replication element (cre), into the 5? non-translated genomic region and inactivating the native cre element located in the coding region of 2C (mono-crePV). The stably attenuated poliovirus replicates in a neuroblastoma model (Neuro-2aCD155 tumors) expressing CD155, the poliovirus receptor, and is effective for oncolytic treatment and cure of solid tumors, such as neuroblastoma.
Type:
Application
Filed:
March 16, 2009
Publication date:
October 1, 2009
Applicant:
The Research Foundation of State University of New York
Abstract: A method and apparatus for recharging a battery of a mobile station are provided which can re-receive a signal emitted from an electromagnetic resonant circuit and automatically recharge the battery having the smallest remaining amount sequentially when a quantity of electric charges remaining in the battery is equal to or less than a reference value while the mobile station is utilizing a mobile communication service. The method includes the steps of: radiating the signal emitted from the electromagnetic resonant circuit; re-receiving the signal emitted from the electromagnetic resonant circuit; activating a conversion of power of the re-received signal; and charging the battery on the basis of a signal obtained by rectifying the re-received signal in accordance with the conversion of power.
Type:
Application
Filed:
March 26, 2009
Publication date:
October 1, 2009
Applicant:
Myongji University Industry and Academia Cooperation Foundation
Abstract: A method of manufacturing a liquid crystal display includes; disposing a thin film transistor having an output terminal on a first substrate, disposing a pixel electrode in connection with the output terminal, disposing an inorganic layer on the pixel electrode, and converting the inorganic layer to a first alignment layer by disposing a mask on the inorganic layer and radiating an ion beam in a plurality of directions.
Type:
Application
Filed:
December 12, 2008
Publication date:
October 1, 2009
Applicants:
Samsung Electronics Co., Ltd., Pusan National University Industry-University Cooperation Foundation
Inventors:
Soon-Joon RHO, Jang-Sub KIM, Baek-Kyun JEON, Hee-Keun LEE, Jae-Chang KIM, Tae-Hoon YOON, Phil-Kook SON, Bong-Kyun JO
Abstract: The invention relates to Factor H gene polymorphisms and haplotypes associated with an elevated or a reduced risk of AMD. The invention provides methods and reagents for diagnosis and treatment of AMD.
Abstract: The present invention provides a method of purifying cross-linked oligomers. The purified cross-linked oligomers are useful as immunogen for generating and isolating cross-linked oligomer reactive antibodies. The cross-linked oligomer reactive antibodies are useful for detecting amyloid deposition and for diagnosing and treating diseases and conditions associated with amyloid deposition.
Type:
Application
Filed:
October 14, 2008
Publication date:
October 1, 2009
Applicant:
University of Tennessee Research Foundation
Inventors:
Brian O'Nuallain, Alan Solomon, Jonathan S. Wall, Luis Acero, Angela Williams
Abstract: The present invention provides therapeutic compositions, kits and methods for treating nervous system injury in a mammal. Certain methods include administering to a mammal in need of such therapy an effective amount of angiopoietin-1 (Ang-1), or a functional analog thereof. Certain methods include administering a peptide having 4 to 20 amino acids that comprises an YVRL (SEQ ID NO:1) motif that may have activity at the ?v?3 or ?5?1 integrin receptor, such as C-16, or a compound that is an agonist at the ?v?3 and/or ?5?1 integrin receptor, which administration may be in combination with administration of Ang-1, or a functional analog thereof.
Type:
Application
Filed:
March 10, 2009
Publication date:
October 1, 2009
Applicant:
University of Louisville Research Foundation
Abstract: Described are recombinant yeast which ferment xylose to ethanol and which maintain their ability to do so when cultured for numerous generations in non-selective media. The preferred yeast contain multiple copies of integrated genes encoding xylose reductase, xylitol dehydrogenase, and xylulokinase fused to promoters which are non-glucose inhibited and which do not require xylose for induction. Also described are preferred methods for integrating multiple copies of exogenous DNA into host cells by transforming cells with replicative/integrative vectors, and then replicating the cells a number of times under selective pressure to promote retention of the vector in subsequent generations. The replicated vectors thus serve to integrate multiple copies of the exogenous DNA into the host cells throughout the replication/selection phase. Thereafter the selective pressure can be removed to promote loss of the vector in subsequent generations, leaving stable integrants of the exogenous DNA.
Abstract: A method and apparatus for encoding and decoding IPM information are provided, in which a coding unit is received, IPMs of a plurality of sub-units included in the coding unit are determined, a relation between an IPM of each sub-unit and IPMs of neighboring sub-units of the each sub-unit is checked, and information about IPMs of a plurality of sub-units according to the relations is encoded in an integrated manner.
Type:
Application
Filed:
March 30, 2009
Publication date:
October 1, 2009
Applicants:
SAMSUNG ELECTRONICS CO., LTD., Sungkyunkwan University Foundation for Corporate Collaboration
Abstract: An intra-prediction coding and decoding method is provided, in which a picture to be encoded is received in coding units, each of the coding units is divided into a plurality of sub-units, an IPM is determined for each coding unit, residual data is acquired for each sub-unit of each coding unit according to the determined IPM, and information about the IPM of each coding unit and the residual data of each sub-unit of each coding unit are encoded.
Type:
Application
Filed:
March 30, 2009
Publication date:
October 1, 2009
Applicants:
SAMSUNG ELECTRONICS CO., LTD., Sungkyunkwan University Foundation for Corporate Collaboration
Abstract: Disclosed is a method for transmitting and receiving data according to a channel state in a wireless communication system, the method includes measuring a characteristic of transmission channels used for data transmission and transmitting channel state information of the measured channel characteristic; and selecting sub-channels for data transmission according to the channel state information, and transmitting data through the selected sub-channels.
Type:
Grant
Filed:
May 12, 2005
Date of Patent:
September 29, 2009
Assignees:
Samsung Electronics Co., Ltd, Seoul National University Industry Foundation
Abstract: Methods for testing candidate drugs for treatment of age-related macular degeneration are provided. Ccl2-deficient, and Ccr2-deficient mice are used to determine the effect of candidate drugs and treatments on development of age-related macular degeneration. Also provided is a Ccl2-deficient, Ccr2-deficient dual knockout mouse, which is a useful animal model for age-related macular degeneration.
Type:
Grant
Filed:
October 16, 2003
Date of Patent:
September 29, 2009
Assignee:
University of Kentucky Research Foundation
Abstract: A computer-assisted detection method is provided for detecting suspicious locations of lesions in the volumetric medical images. The method includes steps of features extraction and fusion. The first step is computing gradient feature for extraction of the layer of Partial Volume Effect (LPVE) between different tissues that related to specific organs. The LPVE will combine with the result of voxel classification to fulfill the task of tissue classification. After tissue classification, the contour of tissue boundary is determined. The gradient feature is also used to determine the direction that intensity changes. This direction that intensity changes most dramatically serves as the normal vector for voxel on the contour of the tissue boundary. The second step is to determine a local surface patch on the contour for each voxel on the contour. A local landmark system is then created on that patch and the so-called Euclidean Distance Transform Vector (EDTV) is computed based on those landmarks.
Type:
Grant
Filed:
September 16, 2002
Date of Patent:
September 29, 2009
Assignee:
The Research Foundation for The State University of New York
Inventors:
Kaufman Arie, Dongqing Chen, Jerome Liang, Mark R. Wax
Abstract: The present invention features a qualitative method to detect independent motion revealed in successive frames of a compressed surveillance MPEG video stream using linear system consistency analysis without decompression of the stream, identifying the segments containing independent motion in a real-time or faster manner, for the retrieval of these segments. The linear system is constructed using the macroblocks of MPEG compressed video frames. The normal flow value of the macroblock is obtained by taking the dot product between the macroblock gradient vector, computed by averaging the four block gradient vectors, and the motion vector of this macroblock. The normal flow value is filtered for inclusion in the linear system, and the statistic of the matrices of the resulting linear system is determined, filtered to screen out false negatives and outliers, and used to determine the presence or absence of independent motion.
Type:
Grant
Filed:
February 12, 2003
Date of Patent:
September 29, 2009
Assignee:
The Research Foundation of State University of New York
Abstract: A method of rejuvenating Leydig cells in a subject having Leydig cells is disclosed. Rejuvenation of Leydig cells is accomplished, in one embodiment, by coadministering TH and LH to a subject. Rejuvenating Leydig cells can enhance serum testosterone levels and can have other desirable effects as well. The presently claimed subject matter also encompasses methods relating to the treatment of andropause and the elevation of serum testosterone levels.
Type:
Grant
Filed:
May 30, 2003
Date of Patent:
September 29, 2009
Assignee:
University of Tennessee Research Foundation
Abstract: The present invention relates to the preparation of a series of oxidized cellulose esters suitable for use as a drug carrier in the development of biodegradable controlled and/or sustained release pharmaceutical, agricultural, and veterinary compositions, such as films, compacts, microspheres, and pellets. The esters are prepared by acylation of oxidized cellulose having at least 3% carboxyl groups. The resulting oxidized cellulose esters are soluble in aqueous alkaline solutions, water, and a variety of organic solvents.
Abstract: The present invention is related to a method for modulating the immune system of a mammal patient towards an allergen, which comprises the step of inducing a pre-sensitisation of the immune system of said patient towards an immunogen carrying at least one T cell epitope homologous and functionally similar to an epitope present on said allergen and deriving from a naturally-occurring antigen in order to modify the response of said patient to a further sensitisation to said allergen, allowing that the immune response towards the allergen is modulated and that no allergy towards said allergen will be developed in said patient.
Abstract: Novel, monodispersed, spherical ZrO2 particles in the size range of approximately 10 to approximately 600 nm exhibiting metastable tetragonal crystal structure at room temperature and novel methods of preparation. The ZrO2 particles are approximately 100% in the tetragonal phase at room temperature and can be pure and free of foreign oxides. The novel method can include mixing zirconium-alkoxide and an alcohol, forming preparation one, followed by separately dissolving completely de-ionized water and a polymeric steric stabilizer in an alcohol forming preparation two. Next the preparations can be mixed with vigorous stirring while subjecting the materials to hydrolysis and condensation reactions with very slow stirring. Next, there is waiting for the formation of a sol from the mixture, followed by drying at approximately 80 degrees C. to form resultant material followed by crushing the resultant material.
Type:
Grant
Filed:
January 15, 2009
Date of Patent:
September 29, 2009
Assignee:
University of Central Florida Research Foundation, Inc.